Compare American Electric Power Company Inc (AEP) vs Bristol-Myers Squibb Co (BMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Electric Power Company Inc vs Bristol-Myers Squibb Co — how do they compare? American Electric Power Company Inc trades at $123.69 (market cap $67.28B), while Bristol-Myers Squibb Co trades at $63.65 (market cap $129.94B). The key difference: Bristol-Myers Squibb Co is the larger of the two by market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| AEP | BMY | |
|---|---|---|
Market Cap | $67.28B | $129.94B |
Sector | Utilities | Health |
52-Week High | $138.69 | $65.89 |
52-Week Low | $106.44 | $42.60 |
Enterprise Value | $120.17B | $163.92B |
Dividend Yield | 3.07% | 3.96% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AEP trades at $124.17, up 1.08% today, with a bearish technical signal but strong fundamentals. Recent Q2 2026 EPS missed estimates at $1.36 versus $1.48 expected, yet revenue grew 7% year-over-year. The company raised 2026 operating EPS guidance to $6.25–$6.55, supported by a $78 billion capital plan and 69 GW of contracted load growth. Analyst consensus is bullish with a $140.89 price target, and dividends remain stable with a $0.95 payment scheduled for September 2026.
Outlook is positive due to robust demand from data centers and regulatory progress, but risks include high debt levels and interest expenses. The stock offers growth potential from AI-driven electricity demand, though valuation premiums and execution risks warrant caution. Near-term support lies at $121, with resistance at $126.
Bristol Myers Squibb (BMY) trades at $63.88, down 1.48% on the day, with strong technical momentum indicated by bullish moving averages and ADX signals. The company demonstrates robust fundamentals with a 14.01 P/E ratio, 18.87% net income margin, and consistent earnings beats in recent quarters. Recent developments include a $2.3 billion manufacturing investment in Houston and strategic AI collaboration with Schrödinger.
BMY presents a compelling investment case with attractive valuation metrics and strong profitability, though investors face risks from patent expirations and debt levels. Analyst consensus suggests 7% upside to the $68.56 price target, with the stock offering dividend income alongside growth potential from pipeline developments and potential M&A activity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Electric Power Company Inc
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →
